Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Wolff

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 30, 2016
Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysisS W L de Geus, D B Evans, L A Bliss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trialsR Said, J Banchs, J Wheler, et al.
Surgery|December 14, 2001
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patientsC C Solorzano, J E Lee, P W Pisters, et al.
International Journal of Gastrointestinal Cancer|January 24, 2003
Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic headC H Crane, J A Antolak, I I Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stentsP W Pisters, W A Hudec, J E Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinomaP W Pisters, J L Abbruzzese, N A Janjan, et al.
Seminars in Oncology|August 18, 2001
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic indexC H Crane, R A Wolff, J L Abbruzzese, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatmentN J Sanfilippo, C H Crane, J Skibber, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|January 14, 2015
Improved Survival with Anti-VEGF Therapy in the Treatment of Unresectable Appendiceal Epithelial NeoplasmsJ H Choe, M J Overman, K F Fournier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 30, 2016
Neoadjuvant therapy versus upfront surgical strategies in resectable pancreatic cancer: A Markov decision analysisS W L de Geus, D B Evans, L A Bliss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2013
The prognostic significance of left ventricular ejection fraction in patients with advanced cancer treated in phase I clinical trialsR Said, J Banchs, J Wheler, et al.
Surgery|December 14, 2001
Nonfunctioning islet cell carcinoma of the pancreas: survival results in a contemporary series of 163 patientsC C Solorzano, J E Lee, P W Pisters, et al.
International Journal of Gastrointestinal Cancer|January 24, 2003
Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic headC H Crane, J A Antolak, I I Rosen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2000
Preoperative chemoradiation for patients with pancreatic cancer: toxicity of endobiliary stentsP W Pisters, W A Hudec, J E Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 1998
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinomaP W Pisters, J L Abbruzzese, N A Janjan, et al.
Seminars in Oncology|August 18, 2001
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic indexC H Crane, R A Wolff, J L Abbruzzese, et al.
Investigational New Drugs|June 12, 2015
Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancerS M Reddy, S Kopetz, J Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|August 23, 2001
T4 rectal cancer treated with preoperative chemoradiation to the posterior pelvis followed by multivisceral resection: patterns of failure and limitations of treatmentN J Sanfilippo, C H Crane, J Skibber, et al.
Pageof 6